Johnson & Johnson is suing the federal government over its rebuke of the company’s alternative model for 340B drug price discounts.
The company asked a …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Researchers have identified a receptor protein known as CHRM1 as a key player in prostate cancer cells’ resistance to docetaxel, a commonly used chemotherapy drug
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS
Research carried out by the UGR, IDIBELL, the Catalan Institute of Oncology and the Biohealth Research Institute in Granada (ibs.GRANADA), published in the journal Environmental